⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21597036 | 0.76 | — | — | |
| SCHEMBL28166441 | 0.68 | — | — | |
| SCHEMBL3442717 | 0.67 | — | — | |
| SCHEMBL4300067 | 0.67 | — | — | |
| SCHEMBL18585114 | 0.67 | — | — | |
| SCHEMBL10512160 | 0.67 | — | — | |
| SCHEMBL6510676 | 0.67 | — | — | |
| SCHEMBL28787552 | 0.67 | — | — | |
| Hydrochloric Acid SCHEMBL22031511 | 0.66 | — | — | |
| SCHEMBL27940574 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104725301-A | Preparation method of 1,2-dihydropyridin-2-one derivative | BEIJING LABWORLD BIO MEDICINE TECHNOLOGY CO LTD | 2015-06-24 | — | — | CN | claimed |
| CN-104649963-A | Preparation technology of perampanel intermediate | SUZHOU LAKESTAR PHARMATECH CO LTD | 2015-05-27 | — | — | CN | claimed |
| CN-102491862-B | Method for preparing biaryl compound in pure water | UNIV DALIAN TECH | 2014-06-25 | — | — | CN | claimed |
| CN-103588597-A | Method for preparing biaryl compound in pure water | UNIV DALIAN TECH | 2014-02-19 | — | — | CN | claimed |
| US-20260015313-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | PEPTIDREAM INC (JP) | 2026-01-15 | — | — | US | disclosed |
| EP-4534524-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | PeptiDream Inc. (JP) | 2025-04-09 | — | — | EP | disclosed |
| WO-2023191469-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS HAVING PHENYL GROUP AND USES THEREOF | 주식회사 비엔에이치리서치 | 2023-10-05 | — | — | WO | disclosed |
| CN-110452216-A | Anti-fibrosis pyridinone | INTERMUNE INC | 2019-11-15 | — | — | CN | disclosed |
| CN-106928194-B | Compounds for the treatment of premature aging and especially premature aging | ABIVAX公司 | 2019-11-12 | — | — | CN | disclosed |
| CN-106715413-B | piperazine derivatives as liver X receptor modulators | VITAE PHARMACEUTICALS, INC. (US) | 2019-11-01 | — | — | CN | disclosed |
| CN-110382494-A | Substituted pyrazolo [1,5-A ] pyridine compounds as RET kinase inhibitors | 阿雷生物药品公司 | 2019-10-25 | — | — | CN | disclosed |
| CN-105085382-B | Pyrrole Lun Panai isomers crystal form and its preparation method and application | 江苏豪森药业集团有限公司 | 2019-10-18 | — | — | CN | disclosed |
| CN-101687842-B | Modulators of CFTR | VERTEX PHARMA | 2013-03-06 | — | — | CN | disclosed |
| CN-102753526-A | Pyridinone hydroxycyclopentyl carboxamides: HIV integrase inhibitors with therapeutic applications | UNIV GEORGIA | 2012-10-24 | — | — | CN | disclosed |
| CN-1585640-B | N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation | ASTRAZENECA AB | 2010-10-27 | — | — | CN | disclosed |
| EP-2142512-A2 | IMIDAZOLIDINE CARBOXAMIDE DERIVATIVES AS P2X7 MODULATORS | Glaxo Group Limited (GB) | 2010-01-13 | — | — | EP | disclosed |
| WO-2008119825-A2 | IMIDAZOLIDINE CARBOXAMIDE DERIVATIVES AS P2X7 MODULATORS | GLAXO GROUP LIMITED (GB) | 2008-10-09 | — | — | WO | disclosed |
| EP-1858876-A2 | PYRIDINONE DERIVATIVES AGAINST MALARIA | GLAXO GROUP LIMITED (GB) | 2007-11-28 | — | — | EP | disclosed |
| WO-2006094799-A2 | PYRIDINONE DERIVATIVES AGAINST MALARIA | GLAXO GROUP LIMITED (GB) | 2006-09-14 | — | — | WO | disclosed |
| CN-1585640-A | N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation | ASTRAZENECA AB (SE) | 2005-02-23 | — | — | CN | disclosed |